Tokyo Tape
Sign in
← Jmdc

Quarterly report · Q1

4483.TEDINET S100P0TK
Period2022-04-01 → 2022-06-30
Filed2022-08-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥5.8bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥21.8bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥4.5bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥1.1bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥823m2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥4.8bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥806m2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥765m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥538m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥759m2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥538m2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥63.3bnat 2022-06-30Cons.Assets IFRS
Total assets¥62.1bnat 2022-03-31Cons.Assets IFRS
Total assets¥57.3bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥31.9bnat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥30.9bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥31.4bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥31.2bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥28.3bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥28.3bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥31.4bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥31.2bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥28.3bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥10.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥13.2bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥17.9bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥19.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥1.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥3.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥805m2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥8.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥1.3bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥909m2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥2.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.4bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥13.552022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥57.742021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥9.622021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥12.732022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥54.162021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥9.032021-04-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio49.7%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.2%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio49.4%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥58m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥90m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥910m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥869m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥41m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥47m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2022-04-01 → 2022-06-30¥3.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2022-04-01 → 2022-06-30¥1.1bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥439m
—segment totalrevenue2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥5.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥58m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.6bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥35m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥35m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥74m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2021-04-01 → 2021-06-30¥782m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2021-04-01 → 2021-06-30¥755m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥27m
jpcrp040300-q1r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2021-04-01 → 2021-06-30¥49m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue2021-04-01 → 2021-06-30¥2.8bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue external2021-04-01 → 2021-06-30¥2.7bn
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥8m
jpcrp040300-q1r_E35308-000Healthcare Big Datareportable segmentsegment profit2021-04-01 → 2021-06-30¥858m
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue2021-04-01 → 2021-06-30¥1.0bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentrevenue external2021-04-01 → 2021-06-30¥1.0bn
jpcrp040300-q1r_E35308-000Tele Medicinereportable segmentsegment profit2021-04-01 → 2021-06-30¥330m
—segment totalrevenue2021-04-01 → 2021-06-30¥4.6bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥4.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥35m
—segment totalsegment profit2021-04-01 → 2021-06-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 683
ItemContextValueUnit
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember400
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember56501500
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember565015
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember12308
Number of shares issued shares voting rightsCurrentQuarterInstant56514208
Number of voting rights issued shares voting rightsCurrentQuarterInstant565015
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member400
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member400
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant400
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant400
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0000
Cash and cash equivalents IFRSPrior1YearInstant13192000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant10128000000JPY
Trade and other receivables ca IFRSPrior1YearInstant9283000000JPY
Trade and other receivables ca IFRSCurrentQuarterInstant9152000000JPY
Other financial assets ca IFRSPrior1YearInstant2561000000JPY
Other financial assets ca IFRSCurrentQuarterInstant2621000000JPY
Inventories ca IFRSPrior1YearInstant248000000JPY
Inventories ca IFRSCurrentQuarterInstant273000000JPY
Other current assets ca IFRSPrior1YearInstant693000000JPY
Other current assets ca IFRSCurrentQuarterInstant656000000JPY
Current assets IFRSPrior1YearInstant25979000000JPY
Current assets IFRSCurrentQuarterInstant22833000000JPY
Property plant and equipment IFRSPrior1YearInstant8420000000JPY
Property plant and equipment IFRSCurrentQuarterInstant9081000000JPY
Goodwill IFRSPrior1YearInstant19169000000JPY
Goodwill IFRSCurrentQuarterInstant22326000000JPY
Intangible assets IFRSPrior1YearInstant5527000000JPY
Intangible assets IFRSCurrentQuarterInstant5686000000JPY
Other financial assets nca IFRSPrior1YearInstant1298000000JPY
Other financial assets nca IFRSCurrentQuarterInstant1548000000JPY
Deferred tax assets IFRSPrior1YearInstant1516000000JPY
Deferred tax assets IFRSCurrentQuarterInstant1650000000JPY
Other non current assets nca IFRSPrior1YearInstant141000000JPY
Other non current assets nca IFRSCurrentQuarterInstant139000000JPY
Non current assets IFRSPrior1YearInstant36073000000JPY
Non current assets IFRSCurrentQuarterInstant40432000000JPY
Assets IFRSPrior1YearInstant62053000000JPY
Assets IFRSCurrentQuarterInstant63265000000JPY
Borrowings cl IFRSPrior1YearInstant777000000JPY
Borrowings cl IFRSCurrentQuarterInstant985000000JPY
Trade and other payables cl IFRSPrior1YearInstant6182000000JPY
Trade and other payables cl IFRSCurrentQuarterInstant6145000000JPY
Lease liabilities cl IFRSPrior1YearInstant689000000JPY
Lease liabilities cl IFRSCurrentQuarterInstant819000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass